Skip to main content
. 2024 Jul 12;62(3):169–175. doi: 10.5114/reum.2024.141289

Table III.

Demographic and disease characteristics for BD patients with and without cognitive impairment

Parameter BD with cognitive impairment (n = 15) Mean ±SD BD without cognitive impairment (n = 25) Mean ±SD Difference
t p
Age [years] 32.14 ±2.97 31.36 ±10.00 –0.66 0.51
Disease duration [years] 6.34 ±2.56 5.12 ±1.44 –0.78 0.44
Education [years] 8.34 ±2.45 10.12 ±3.24 0.44 0.67
BDCAF 10.81 ±6.23 9.56 ±6.13 –0.27 0.80
SCL-90-R for depression 29.56 ±9.67 21.56 ±8.65 –2.68 0.01*
SCL-90-R for anxiety 13.86 ±3.07 10.23 ±2.83 –1.32 0.20
Mean dose of corticosteroids (mg/day) 30.50 ±7.90 19.87 ±3.23 –2.71 0.01*

BDCAF – Behçet’s Disease Current Activity Form, SCL-90-R – Symptom Checklist-90-Revised.

*

p< 0.05 significant difference.